BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 37679006)

  • 21. Pegylated Liposomal Doxorubicin Is an Active Agent for Chemotherapy-Resistant Choriocarcinoma: A Report of Two Cases.
    Popadiuk C; Power P
    J Reprod Med; 2016; 61(5-6):215-8. PubMed ID: 27424361
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment results of the second-line chemotherapy regimen for patients with low-risk gestational trophoblastic neoplasia treated with 5-day methotrexate and 5-day etoposide.
    Kanno T; Matsui H; Akizawa Y; Usui H; Shozu M
    J Gynecol Oncol; 2018 Nov; 29(6):e89. PubMed ID: 30207097
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intracerebral hemorrhage as initial presentation of gestational choriocarcinoma: a case report and literature review.
    Huang CY; Chen CA; Hsieh CY; Cheng WF
    Int J Gynecol Cancer; 2007; 17(5):1166-71. PubMed ID: 17425677
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Salvage chemotherapy for gestational trophoblastic neoplasia: Utility or futility?
    Essel KG; Bruegl A; Gershenson DM; Ramondetta LM; Naumann RW; Brown J
    Gynecol Oncol; 2017 Jul; 146(1):74-80. PubMed ID: 28473205
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Current chemotherapeutic options for the treatment of gestational trophoblastic disease.
    Braga A; Paiva G; Cattai CJ; Elias KM; Horowitz NS; Berkowitz RS
    Expert Opin Pharmacother; 2023 Feb; 24(2):245-258. PubMed ID: 36399723
    [TBL] [Abstract][Full Text] [Related]  

  • 26. EP-EMA regimen (etoposide and cisplatin with etoposide, methotrexate, and dactinomycin) in a series of 18 women with gestational trophoblastic neoplasia.
    Han SN; Amant F; Leunen K; Devi UK; Neven P; Vergote I
    Int J Gynecol Cancer; 2012 Jun; 22(5):875-80. PubMed ID: 22635033
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lung metastases in low-risk gestational trophoblastic neoplasia: a retrospective cohort study.
    Frijstein MM; Lok C; van Trommel NE; Ten Kate-Booij MJ; Massuger L; van Werkhoven E; Short D; Aguiar X; Fisher RA; Kaur B; Sarwar N; Sebire NJ; Seckl MJ
    BJOG; 2020 Feb; 127(3):389-395. PubMed ID: 31794098
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Choriocarcinoma After Term Pregnancy With a Subsequent Successful Pregnancy: A Rare Entity.
    Sapantzoglou I; Giourga M; Psarris A; Daskalakis G; Domali E
    Cureus; 2023 Oct; 15(10):e47583. PubMed ID: 38022303
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Short tandem repeat analysis to identify the causative pregnancy of high-risk gestational trophoblastic neoplasia: Molar versus nonmolar pregnancy and its relation to the outcome.
    Nishino K; Yamamoto E; Oda Y; Watanabe E; Niimi K; Yamamoto T; Kajiyama H
    Placenta; 2021 Sep; 112():28-35. PubMed ID: 34247032
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk adapted single-agent dactinomycin or carboplatin for second-line treatment of methotrexate resistant low-risk gestational trophoblastic neoplasia.
    Winter MC; Tidy JA; Hills A; Ireson J; Gillett S; Singh K; Hancock BW; Coleman RE
    Gynecol Oncol; 2016 Dec; 143(3):565-570. PubMed ID: 27756557
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [EMA/CO regimen for chemotherapy 24 patients with ultra high-risk gestational trophoblastic neoplasia].
    Shen T; Chen LL; Qin JL; Wang XY; Cheng XD; Xie X; Lyu WG
    Zhonghua Fu Chan Ke Za Zhi; 2018 Jun; 53(6):371-376. PubMed ID: 29961278
    [No Abstract]   [Full Text] [Related]  

  • 32. Efficacy analysis of single-agent carboplatin AUC4 2-weekly as second-line therapy for methotrexate-resistant (MTX-R) low risk gestational trophoblastic neoplasia (GTN).
    Winter MC; Tidy JA; Singh K; Sarwar N; Aguiar X; Seckl MJ
    Gynecol Oncol; 2023 Aug; 175():66-71. PubMed ID: 37327541
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gestational trophoblastic neoplasia after achieving a nondetectable serum human chorionic gonadotrophin level.
    Gueye M; Kane-Gueye SM; Ndiaye-Gueye MD; Mbaye M; Diouf AA; Niang MM; Diallo M; Moreau JC
    BJOG; 2014 Oct; 121(11):1415-9. PubMed ID: 24674295
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Rare Case of Combined Choriocarcinoma and Placental Site Trophoblastic Tumor Presenting as Skin Lesion: A Case Report.
    Chatterjee T; Martial A; Settypalli S; Lindahl L
    Am J Case Rep; 2022 Jun; 23():e936451. PubMed ID: 35715940
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The added value of hysterectomy in the management of gestational trophoblastic neoplasia.
    Eysbouts YK; Massuger LFAG; IntHout J; Lok CAR; Sweep FCGJ; Ottevanger PB
    Gynecol Oncol; 2017 Jun; 145(3):536-542. PubMed ID: 28390821
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metastatic choriocarcinoma successfully treated with paclitaxel and carboplatin after interstitial lung disease induced by EMA-CO.
    Amikura T; Aoki Y; Banzai C; Yokoo T; Nishikawa N; Sekine M; Suzuki M; Tanaka K
    Gynecol Oncol; 2006 Sep; 102(3):573-5. PubMed ID: 16580712
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epithelioid trophoblastic tumor coexisting with choriocarcinoma around an abdominal wall cesarean scar: a case report and review of the literature.
    Yang C; Li J; Zhang Y; Xiong H; Sheng X
    J Med Case Rep; 2020 Oct; 14(1):178. PubMed ID: 33012293
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High-dose chemotherapy with autologous peripheral blood stem cell transplantation for choriocarcinoma: A case report and literature review.
    Yamamoto E; Niimi K; Fujikake K; Nishida T; Murata M; Mitsuma A; Ando Y; Kikkawa F
    Mol Clin Oncol; 2016 Nov; 5(5):660-664. PubMed ID: 27900108
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combination chemotherapy for primary treatment of high-risk gestational trophoblastic tumour.
    Deng L; Zhang J; Wu T; Lawrie TA
    Cochrane Database Syst Rev; 2013 Jan; 2013(1):CD005196. PubMed ID: 23440800
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Leptomeningeal disease as a presenting feature of gestational trophoblastic neoplasia: A review and recommendations for management.
    Hapuarachi B; Tidy JA; Romanowski C; Singh K; Gillett S; Ireson J; Winter MC
    Gynecol Oncol; 2023 May; 172():47-53. PubMed ID: 36934478
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.